BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27181226)

  • 1. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
    Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
    Dowsett L; Piper S; Slaviero A; Dufton N; Wang Z; Boruc O; Delahaye M; Colman L; Kalk E; Tomlinson J; Birdsey G; Randi AM; Leiper J
    Circulation; 2015 Jun; 131(25):2217-25. PubMed ID: 25910799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase.
    Ragavan VN; Nair PC; Jarzebska N; Angom RS; Ruta L; Bianconi E; Grottelli S; Tararova ND; Ryazanskiy D; Lentz SR; Tommasi S; Martens-Lobenhoffer J; Suzuki-Yamamoto T; Kimoto M; Rubets E; Chau S; Chen Y; Hu X; Bernhardt N; Spieth PM; Weiss N; Bornstein SR; Mukhopadhyay D; Bode-Böger SM; Maas R; Wang Y; Macchiarulo A; Mangoni AA; Cellini B; Rodionov RN
    Nat Commun; 2023 Jun; 14(1):3392. PubMed ID: 37296100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis.
    Lambden S; Kelly P; Ahmetaj-Shala B; Wang Z; Lee B; Nandi M; Torondel B; Delahaye M; Dowsett L; Piper S; Tomlinson J; Caplin B; Colman L; Boruc O; Slaviero A; Zhao L; Oliver E; Khadayate S; Singer M; Arrigoni F; Leiper J
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1382-92. PubMed ID: 25857313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
    Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
    Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
    ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma.
    Kinker KG; Gibson AM; Bass SA; Day BP; Deng J; Medvedovic M; Figueroa JA; Hershey GK; Chen W
    PLoS One; 2014; 9(1):e85148. PubMed ID: 24465497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW; Xiong Y; He P
    Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P; Hu X; Xu X; Chen Y; Bache RJ
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway.
    Du MR; Yan L; Li NS; Wang YJ; Zhou T; Jiang JL
    Vascul Pharmacol; 2018 Sep; 108():46-56. PubMed ID: 29777874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
    Zhang P; Fassett JT; Zhu G; Li J; Hu X; Xu X; Chen Y; Bache RJ
    Vasc Med; 2017 Jun; 22(3):179-188. PubMed ID: 28145161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S; Burdon KP; Kuot A; Javadiyan S; Whiting MJ; Kasmeridis N; Petrovsky N; Craig JE
    PLoS One; 2010 Mar; 5(3):e9462. PubMed ID: 20209122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial TWIST1 promotes pathological ocular angiogenesis.
    Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.